Authors: TAMMINGA CA MACK RJ GRANNEMAN GR SILBER CJ KASHKIN KB

Citation: Ca. Tamminga et al., SERTINDOLE IN THE TREATMENT OF PSYCHOSIS IN SCHIZOPHRENIA - EFFICACY AND SAFETY, International clinical psychopharmacology, 12, 1997, pp. 29-35

Authors: ZIMBROFF DL KANE JM TAMMINGA CA DANIEL DG MACK RJ WOZNIAK PJ SEBREE TB WALLIN BA KASHKIN KB ADAN F AINSLIE G ALLAN E ATRI P BAKER R BEITMAN B BROWN G CANIVE J CARMAN J DOTT S EDWARDS J FENTON W FREIDLI J FUNDERBURG L ERESHEFSKY L GLADSON M HAMILTON J HAQUE S HARTFORD J HORNE R HOUCK C JAMPALA C LABELLE A LARSON G LESEM M LISKOW B MAKELA E MOORE N MORPHY M POSEVER T RISCH S ROTROSEN J SHEEHAN D SILVERSTONE P SWANN A TAPP A THOMAS M VOLAVKA J VORA S

Citation: Dl. Zimbroff et al., CONTROLLED, DOSE-RESPONSE STUDY OF SERTINDOLE AND HALOPERIDOL IN THE TREATMENT OF SCHIZOPHRENIA, The American journal of psychiatry, 154(6), 1997, pp. 782-791

Authors: MARTIN PT GREBB JA SCHMITZ PJ SEBREE TB KASHKIN KB

Citation: Pt. Martin et al., EFFICACY AND SAFETY OF SERTINDOLE IN DOUBLE-BLIND, PLACEBO-CONTROLLEDTRIALS OF SCHIZOPHRENIC-PATIENTS, Schizophrenia research, 11(2), 1994, pp. 107-107

Authors: GREBB JA KITTLE C SEBREE T KASHKIN KB

Citation: Ja. Grebb et al., A PILOT-STUDY OF THE EFFICACY AND SAFETY OF A-81418 IN REDUCING SYMPTOMS OF NICOTINE WITHDRAWAL, Biological psychiatry, 35(9), 1994, pp. 691-691